Yingke Biopharmaceutical
Taizhou
About Yingke Biopharmaceutical
Yingke Biopharmaceutical operates as a high-tech biopharmaceutical enterprise integrating R&D, production and sales.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $42.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2023)
- Website: yk-bio.com
Industries & Categories
Biopharma, Pharmaceutical
Canonical: https://fsome.com/organization/yingke-biopharmaceutical-55304 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.